Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    July 9, 2015

    Defining your Cell Therapy: The Importance of a Quality Target Product Profile

    Before any cell therapy company can begin manufacturing a therapy, or designing and engineering the production equipment, it is necessary to engage in detailed ...

    Read More
    July 11, 2014

    PCT Experts Robert Shaw, Brian Hampson and Candice Betz Publish in BioProcessing Journal

    PCT experts Robert Shaw, VP, Commercial Development; Brian Hampson, VP Manufacturing Development & Engineering, and Candice Betz, Director of QA/QC, have recently ...

    Read More
    October 23, 2012

    Beyond Scale-up, Part 4 of 4: Delivery Method Effect on Resource Demand

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-up, Part 3 of 4: Success by Design

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-Up, Part 2 of 4: Focus on Product Delivery

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    October 23, 2012

    Beyond Scale-Up: Managing Cost and Bedside Integrity of Cell Therapy Products in a Commercial Setting, Part 1 of 4

    By Sanjin Zvonic, PhD, Director, Technology & Business Development

    Read More
    May 23, 2012

    PCT Celebrates 20 Years of ISCT

    2012 marks the 20th anniversary of the formation of the International Society for Cellular Therapy (ISCT). ISCT was first conceived by a handful of pioneers at a ...

    Read More
    January 23, 2012

    Bench To Bedside: Cell Therapy Development and Commercialization Roadmap

    PCT's Dr. Sanjin Zvonic, drawing on more than 12 years of PCT's philosophy, experience and expertise, gives an overview of the key steps in the commercialization of cell ...

    Read More
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint